124 related articles for article (PubMed ID: 33275396)
1. Association between plasma prostaglandin E2 level and colorectal cancer.
Wang F; Wang M; Yin H; Long Z; Zhu L; Yu H; Sun H; Bi H; Li S; Zhao Y; Dong X; Zhou J
Eur J Cancer Prev; 2021 Jan; 30(1):59-68. PubMed ID: 33275396
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.
Pereira C; Queirós S; Galaghar A; Sousa H; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
PLoS One; 2014; 9(4):e92000. PubMed ID: 24694755
[TBL] [Abstract][Full Text] [Related]
3. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
4. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
Poole EM; Hsu L; Xiao L; Kulmacz RJ; Carlson CS; Rabinovitch PS; Makar KW; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):547-57. PubMed ID: 20086108
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.
Fawzy MS; Aly NM; Shalaby SM; El-Sawy WH; Abdul-Maksoud RS
Gene; 2013 Sep; 527(2):601-5. PubMed ID: 23792017
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
[TBL] [Abstract][Full Text] [Related]
8. A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.
Edwards TL; Shrubsole MJ; Cai Q; Li G; Dai Q; Rex DK; Ulbright TM; Fu Z; Murff HJ; Smalley W; Ness R; Zheng W
Cancer Prev Res (Phila); 2012 Jun; 5(6):855-63. PubMed ID: 22551900
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
10. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
Daraei A; Salehi R; Mohamadhashem F
Mol Biol Rep; 2012 May; 39(5):5219-24. PubMed ID: 22173719
[TBL] [Abstract][Full Text] [Related]
11. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin Endoperoxide H Synthase-2 (PGHS-2) Variants and Risk of Obesity and Microvascular Dysfunction Among Tunisians: Relevance of rs5277 (306G/C) and rs5275 (8473T/C) Genetic Markers.
Touir A; Boumiza S; Nasr HB; Bchir S; Tabka Z; Norel X; Chahed K
Biochem Genet; 2021 Dec; 59(6):1457-1486. PubMed ID: 33929697
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
Cox DG; Pontes C; Guino E; Navarro M; Osorio A; Canzian F; Moreno V;
Br J Cancer; 2004 Jul; 91(2):339-43. PubMed ID: 15173859
[TBL] [Abstract][Full Text] [Related]
14. Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.
Wu H; Xu L; Chen J; Hu J; Yu S; Hu G; Huang L; Chen X; Yuan X; Li G
BMC Cancer; 2012 Jul; 12():276. PubMed ID: 22759347
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.
Siezen CL; Tijhuis MJ; Kram NR; van Soest EM; de Jong DJ; Fodde R; van Kranen HJ; Kampman E
Pharmacogenet Genomics; 2006 Jan; 16(1):43-50. PubMed ID: 16344721
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.
Lurie G; Terry KL; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Palmieri RT; Cramer DW; Goodman MT
Cancer Causes Control; 2010 Oct; 21(10):1731-41. PubMed ID: 20559705
[TBL] [Abstract][Full Text] [Related]
17. An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.
Ross J; Lockett L; Brookes D; Tabor B; Duesing K; Buckley M; Lockett T; Molloy P; Macrae F; Young G; Blanco I; Capella G; Hannan GN
Eur J Hum Genet; 2013 Dec; 21(12):1389-95. PubMed ID: 23531863
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
[TBL] [Abstract][Full Text] [Related]
19. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S; Kaidi A; Williams AC; Paraskeva C
Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
Nagao M; Sato Y; Yamauchi A
PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
